In 2013, the unthinkable happened for grandparents Judy and Henry Sauer when their 13-year-old grandson was diagnosed with Langerhans cell histiocytosis (LCH). LCH is a rare disease that can affect both children and adults and is characterized by an overabundance of abnormal dendritic cells that cause damage to the skin, bone and other organs.
With their grandson undergoing treatment at Texas Children’s, which houses the largest Histiocytosis Program in the world, the Sauers got to work raising awareness and funds. They partnered with others in the community who shared a passion for the Histiocytosis Program at Texas Children's and chaired an annual event that provided transformational funding for the program. This support was instrumental in developing and expanding clinical trials of innovative therapies. Unlike other rare white blood cell disorders, such as acute myelogenous leukemia or lymphoma, the cell of origin and the causes of LCH and other forms of histiocytosis remain unknown.
Ten years after his LCH diagnosis, the Sauers’ grandson is a thriving young adult and recent college graduate, who double majored in economics and mathematics and is pursuing a career in investment banking. His family is still thankful for the innovative and successful treatment he received at Texas Children’s and, last year, Judy and Henry decided to make an impactful philanthropic gift that will benefit patients with histiocytosis and their families now and in the future.
Working closely with the Office of Philanthropy and the directors of the Histiocytosis Program, Dr. Kenneth McClain and Dr. Carl Allen, the Sauers named the Judy and Henry Sauer, Jr. Histiocytosis Program and established two funds — a permanent endowed fund and an immediately available accelerator fund — through a blended gift, combining an outright gift with a future contribution through their estates. By structuring their support in this way, the Sauers are able to see the impact of their generosity today while ensuring a transformative future for histiocytosis research and care at Texas Children’s.
“We are deeply grateful for this incredible gift from our dear friends, Judy and Henry,” shared Drs. Allen and McClain. “This transformational gift will provide the necessary support to allow us to focus on the Judy and Henry Sauer, Jr. Histiocytosis Program’s greatest needs and advance patient care now and in the future. Their generosity helps ensure Texas Children’s remains the leader in histiocytosis research, education and patient care.”
Contact Rachel S. Kronenberger at 832-824-6907 or rskronen@texaschildrens.org to discover how you can easily support our mission through a blended gift.